4300 EL CAMINO REAL, SUITE 210, LOS ALTOS, CA
Other Events
Annual Meeting Results: Three Directors Elected at Unicycive Therapeutics
Amendment to Sales Agreement Increases ATM Offering to $150 Million
Announces First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Director Resignation - Gaurav Aggarwal Steps Down from Board
Financial Results, Press Release
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Amended Statement of Changes in Beneficial Ownership